GG
Gleason Group’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Buy |
1,543
+3
| +0.2% | +$2.34K | 0.13% | 37 |
|
|
2025
Q1 | $1.27M | Buy |
1,540
+2
| +0.1% | +$1.65K | 0.23% | 32 |
|
|
2024
Q4 | $1.19M | Sell |
1,538
-711
| -32% | -$549K | 0.21% | 32 |
|
|
2024
Q3 | $1.99M | Buy |
2,249
+1
| +0% | +$886 | 0.36% | 24 |
|
|
2024
Q2 | $2.04M | Buy |
2,248
+3
| +0.1% | +$2.72K | 0.41% | 21 |
|
|
2024
Q1 | $1.75M | Buy |
2,245
+2
| +0.1% | +$1.56K | 0.37% | 25 |
|
|
2023
Q4 | $1.31M | Sell |
2,243
-40
| -2% | -$23.3K | 0.3% | 27 |
|
|
2023
Q3 | $1.23M | Buy |
2,283
+5
| +0.2% | +$2.69K | 0.32% | 26 |
|
|
2023
Q2 | $1.07M | Buy |
2,278
+5
| +0.2% | +$2.35K | 0.28% | 34 |
|
|
2023
Q1 | $780K | Buy |
2,273
+331
| +17% | +$114K | 0.22% | 40 |
|
|
2022
Q4 | $710K | Buy |
1,942
+6
| +0.3% | +$2.2K | 0.22% | 43 |
|
|
2022
Q3 | $626K | Buy |
1,936
+6
| +0.3% | +$1.94K | 0.22% | 38 |
|
|
2022
Q2 | $626K | Buy |
1,930
+6
| +0.3% | +$1.95K | 0.22% | 40 |
|
|
2022
Q1 | $551K | Buy |
1,924
+7
| +0.4% | +$2.01K | 0.16% | 43 |
|
|
2021
Q4 | $530K | Buy |
1,917
+7
| +0.4% | +$1.94K | 0.17% | 47 |
|
|
2021
Q3 | $441K | Buy |
1,910
+6
| +0.3% | +$1.39K | 0.16% | 49 |
|
|
2021
Q2 | $437K | Buy |
1,904
+8
| +0.4% | +$1.84K | 0.16% | 50 |
|
|
2021
Q1 | $354K | Buy |
1,896
+7
| +0.4% | +$1.31K | 0.14% | 51 |
|
|
2020
Q4 | $319K | Sell |
1,889
-594
| -24% | -$100K | 0.15% | 52 |
|
|
2020
Q3 | $368K | Sell |
2,483
-206
| -8% | -$30.5K | 0.21% | 47 |
|
|
2020
Q2 | $441K | Sell |
2,689
-87
| -3% | -$14.3K | 0.27% | 41 |
|
|
2020
Q1 | $385K | Sell |
2,776
-35
| -1% | -$4.85K | 0.3% | 40 |
|
|
2019
Q4 | $369K | Buy |
+2,811
| New | +$369K | 0.22% | 45 |
|